Skin Conditions in Dogs: Welfare Management and Care

Canine Skin Conditions: A Welfare Overview

Skin disease is one of the most common reasons dogs are presented to veterinarians, accounting for approximately 25–30% of all small animal consultations. The welfare impact of chronic skin conditions — constant itching, broken sleep, secondary infection pain, and the frustration of being unable to relieve itch through normal grooming — is significant and often underestimated. Early, accurate diagnosis and appropriate management are essential for maximising quality of life in affected dogs.

Atopic Dermatitis (Environmental Allergy)

Canine atopic dermatitis (cAD) is a chronic, relapsing inflammatory skin condition driven by hypersensitivity to environmental allergens (house dust mites, pollens, moulds, storage mites). It affects 10–15% of dogs and is one of the most common chronic disease in veterinary medicine.

Signs

Pruritus (itching) — particularly face, ears, paws, armpits, and groin
Recurrent ear infections (otitis externa)
Skin lichenification (thickening) from chronic trauma
Alopecia (hair loss) from self-trauma
Recurrent secondary bacterial (Staphylococcus) and yeast (Malassezia) infections

Management

Allergen-specific immunotherapy (desensitisation) — the only treatment that modifies the underlying disease; 60–70% response rate
Oclacitinib (Apoquel): JAK inhibitor; rapid itch control; once or twice daily tablet
Lokivetmab (Cytopoint): Monthly injection; anti-IL-31 antibody; very safe; excellent for many dogs
Cyclosporine (Atopica): Effective; takes 4–6 weeks to reach effect
Skin barrier maintenance (medicated shampoos, essential fatty acid supplementation)

Food Allergy/Adverse Food Reaction

Food allergies in dogs present similarly to atopic dermatitis but with potentially year-round signs and resistance to seasonal variation. Common food allergens: beef, chicken, dairy, wheat, egg.

Diagnosis requires strict dietary elimination trial — novel or hydrolysed protein diet for minimum 8 weeks
No contamination during trial — no treats, table scraps, flavoured medications
Resolution during trial and recurrence on rechallenge confirms food allergy
Management: avoid identified allergens; commercial hypoallergenic diets for life

Parasitic Skin Conditions

Sarcoptic Mange (Scabies)

Caused by Sarcoptes scabiei mite; intensely pruritic; transmissible to humans
Crusting, hair loss on ear margins, elbows, hocks; spreads rapidly
Treatment: isoxazoline antiparasitic (fluralaner, sarolaner, afoxolaner) — highly effective

Demodicosis

Caused by Demodex canis mite; typically occurs in immunosuppressed dogs
Localised (usually self-limiting) vs. generalised (requires treatment)
Isoxazoline treatments very effective for generalised demodicosis

Bacterial Skin Infections (Pyoderma)

Secondary to pruritic skin disease, trauma, or immune compromise:

Surface (hot spots/acute moist dermatitis): Clip, clean, topical antiseptic
Superficial pyoderma: Systemic antibiotics (culture-guided to avoid resistance)
Deep pyoderma: Prolonged antibiotics; often underlying disease driving recurrence

Welfare Impact of Chronic Skin Disease

Chronic pruritus severely impacts quality of life:

Sleep disruption from nocturnal scratching
Constant distraction from itch reducing engagement with normal activities
Secondary infections causing pain in addition to itch
Frustration and anxiety from inability to relieve itch normally

The development of biologic treatments (Cytopoint) and JAK inhibitors (Apoquel) represents a genuine welfare advance — rapid, effective itch control that dramatically improves quality of life within days.